Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Aplastic | 2 | 2019 | 231 | 0.780 |
Why?
|
Lymphoma, Primary Cutaneous Anaplastic Large Cell | 1 | 2018 | 8 | 0.640 |
Why?
|
Kaposi Varicelliform Eruption | 1 | 2018 | 47 | 0.610 |
Why?
|
Hepatitis E | 1 | 2017 | 76 | 0.510 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2019 | 614 | 0.490 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2017 | 147 | 0.490 |
Why?
|
Hematologic Diseases | 2 | 2010 | 498 | 0.460 |
Why?
|
Mycosis Fungoides | 2 | 2012 | 169 | 0.400 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2019 | 1375 | 0.390 |
Why?
|
Thrombocytopenia | 3 | 2006 | 1179 | 0.370 |
Why?
|
Skin Neoplasms | 8 | 2021 | 5863 | 0.370 |
Why?
|
Hematologic Agents | 1 | 2010 | 39 | 0.340 |
Why?
|
Biological Products | 1 | 2018 | 948 | 0.320 |
Why?
|
Glioblastoma | 1 | 2019 | 3464 | 0.230 |
Why?
|
Medical Oncology | 2 | 2022 | 2346 | 0.210 |
Why?
|
Adenovirus E1A Proteins | 2 | 2000 | 81 | 0.200 |
Why?
|
Kanamycin Kinase | 2 | 1998 | 34 | 0.190 |
Why?
|
Myasthenia Gravis | 1 | 2024 | 215 | 0.180 |
Why?
|
Neoplasms, Adnexal and Skin Appendage | 1 | 2021 | 26 | 0.180 |
Why?
|
Heparin | 2 | 2006 | 1636 | 0.180 |
Why?
|
Myositis | 1 | 2024 | 269 | 0.180 |
Why?
|
Lymphomatoid Papulosis | 1 | 2000 | 16 | 0.180 |
Why?
|
Blood Coagulation Disorders | 1 | 2003 | 350 | 0.170 |
Why?
|
Melanoma | 1 | 2018 | 5706 | 0.170 |
Why?
|
Hematology | 1 | 2023 | 243 | 0.170 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2000 | 378 | 0.160 |
Why?
|
Critical Illness | 2 | 2003 | 2756 | 0.160 |
Why?
|
Fatal Outcome | 3 | 2019 | 1836 | 0.150 |
Why?
|
Quality of Health Care | 1 | 2013 | 4310 | 0.150 |
Why?
|
Disabled Persons | 4 | 2008 | 1210 | 0.150 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9118 | 0.150 |
Why?
|
Gene Rearrangement | 2 | 2000 | 1146 | 0.140 |
Why?
|
Blood Transfusion | 1 | 2003 | 1309 | 0.140 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2021 | 737 | 0.130 |
Why?
|
Pentosyltransferases | 1 | 1996 | 62 | 0.130 |
Why?
|
Career Choice | 1 | 2022 | 769 | 0.130 |
Why?
|
Electronic Health Records | 1 | 2013 | 4887 | 0.120 |
Why?
|
DNA Helicases | 1 | 2000 | 854 | 0.120 |
Why?
|
Adenoviridae | 1 | 1998 | 1092 | 0.110 |
Why?
|
Lichen Planus | 1 | 2015 | 70 | 0.110 |
Why?
|
Incidental Findings | 1 | 2019 | 698 | 0.110 |
Why?
|
Anemia | 1 | 2003 | 1514 | 0.110 |
Why?
|
Medicare | 6 | 2008 | 6809 | 0.110 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1135 | 0.110 |
Why?
|
Mycophenolic Acid | 1 | 1996 | 348 | 0.110 |
Why?
|
Herpesvirus 1, Human | 1 | 2018 | 743 | 0.110 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2914 | 0.100 |
Why?
|
Oncolytic Virotherapy | 1 | 2018 | 520 | 0.100 |
Why?
|
Gene Deletion | 1 | 2000 | 2675 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4058 | 0.100 |
Why?
|
Phosphotransferases | 1 | 1992 | 302 | 0.090 |
Why?
|
Critical Care | 1 | 2003 | 2715 | 0.090 |
Why?
|
Oncology Service, Hospital | 1 | 1991 | 56 | 0.090 |
Why?
|
Lymphoma, T-Cell | 2 | 2004 | 308 | 0.090 |
Why?
|
Anticoagulants | 1 | 2006 | 4852 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2000 | 1437 | 0.080 |
Why?
|
3T3 Cells | 3 | 1998 | 1084 | 0.080 |
Why?
|
Social Security | 2 | 2007 | 101 | 0.080 |
Why?
|
Mastectomy | 2 | 2008 | 1861 | 0.080 |
Why?
|
Neoplasms | 4 | 2010 | 22371 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2846 | 0.070 |
Why?
|
Clinical Competence | 1 | 2023 | 4858 | 0.070 |
Why?
|
Aged, 80 and over | 4 | 2024 | 59629 | 0.070 |
Why?
|
Gentamicins | 2 | 1998 | 244 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9419 | 0.070 |
Why?
|
Humans | 29 | 2024 | 768166 | 0.070 |
Why?
|
Acute Disease | 1 | 2017 | 7243 | 0.070 |
Why?
|
Oncogenes | 1 | 1992 | 1234 | 0.060 |
Why?
|
Medical Informatics | 1 | 2013 | 743 | 0.060 |
Why?
|
SEER Program | 5 | 2008 | 1444 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2020 | 4262 | 0.060 |
Why?
|
Male | 14 | 2024 | 364719 | 0.060 |
Why?
|
Complement Inactivating Agents | 1 | 2024 | 53 | 0.060 |
Why?
|
Transfection | 3 | 1998 | 5755 | 0.050 |
Why?
|
Restriction Mapping | 2 | 1996 | 849 | 0.050 |
Why?
|
Patient Admission | 1 | 1991 | 1365 | 0.050 |
Why?
|
Methyltransferases | 1 | 2006 | 373 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2784 | 0.050 |
Why?
|
Prednisone | 2 | 2024 | 1567 | 0.050 |
Why?
|
Cell Division | 3 | 2000 | 4473 | 0.050 |
Why?
|
Reed-Sternberg Cells | 1 | 2001 | 78 | 0.050 |
Why?
|
Erythropoietin | 1 | 2006 | 718 | 0.050 |
Why?
|
Mastectomy, Segmental | 1 | 2006 | 974 | 0.050 |
Why?
|
Hemostasis | 1 | 2003 | 468 | 0.050 |
Why?
|
Pityriasis Lichenoides | 1 | 2000 | 6 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 1991 | 2008 | 0.040 |
Why?
|
HELLP Syndrome | 1 | 2000 | 40 | 0.040 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2420 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8542 | 0.040 |
Why?
|
Accreditation | 1 | 2023 | 476 | 0.040 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2000 | 106 | 0.040 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2000 | 187 | 0.040 |
Why?
|
North America | 1 | 2023 | 1289 | 0.040 |
Why?
|
Lymph Node Excision | 2 | 2021 | 1271 | 0.040 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2000 | 131 | 0.040 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2000 | 168 | 0.040 |
Why?
|
Mohs Surgery | 1 | 2021 | 217 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2008 | 5432 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 1992 | 7608 | 0.040 |
Why?
|
Genetic Complementation Test | 1 | 1998 | 557 | 0.040 |
Why?
|
Methotrexate | 1 | 2004 | 1721 | 0.040 |
Why?
|
Platelet Transfusion | 1 | 2000 | 301 | 0.040 |
Why?
|
Attitude to Death | 1 | 2000 | 400 | 0.030 |
Why?
|
Clone Cells | 2 | 2001 | 1670 | 0.030 |
Why?
|
Hygromycin B | 1 | 1996 | 11 | 0.030 |
Why?
|
Cell Size | 1 | 1998 | 626 | 0.030 |
Why?
|
Puromycin | 1 | 1996 | 41 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2000 | 426 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2748 | 0.030 |
Why?
|
Diagnosis, Differential | 4 | 2015 | 13014 | 0.030 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1996 | 188 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1992 | 8647 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2000 | 1864 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2000 | 4168 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4598 | 0.030 |
Why?
|
Survival Rate | 3 | 2021 | 12840 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2000 | 977 | 0.030 |
Why?
|
Remission Induction | 1 | 2000 | 2410 | 0.030 |
Why?
|
Lung Neoplasms | 4 | 2008 | 13586 | 0.030 |
Why?
|
Sequence Deletion | 1 | 1998 | 1497 | 0.030 |
Why?
|
Colonic Neoplasms | 2 | 2000 | 2541 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5458 | 0.030 |
Why?
|
RNA Splicing | 1 | 1998 | 905 | 0.030 |
Why?
|
Hodgkin Disease | 1 | 2001 | 1384 | 0.030 |
Why?
|
Breast Neoplasms | 4 | 2008 | 21206 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 11878 | 0.030 |
Why?
|
POEMS Syndrome | 1 | 1992 | 12 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2004 | 4352 | 0.030 |
Why?
|
Base Sequence | 2 | 2001 | 12421 | 0.030 |
Why?
|
Cell Line | 2 | 2000 | 15597 | 0.030 |
Why?
|
Survival Analysis | 2 | 2008 | 10101 | 0.030 |
Why?
|
Neoplasm Staging | 4 | 2008 | 11244 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 1998 | 1750 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2008 | 3415 | 0.020 |
Why?
|
Brain | 1 | 2019 | 27360 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2008 | 1791 | 0.020 |
Why?
|
Aged | 8 | 2021 | 171504 | 0.020 |
Why?
|
Telangiectasis | 1 | 1991 | 78 | 0.020 |
Why?
|
Lymphoma | 1 | 2000 | 1898 | 0.020 |
Why?
|
Health Services Research | 2 | 2007 | 1815 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2001 | 17622 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1992 | 775 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2004 | 1126 | 0.020 |
Why?
|
Pre-Eclampsia | 1 | 2000 | 1255 | 0.020 |
Why?
|
Catastrophic Illness | 1 | 1991 | 60 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6526 | 0.020 |
Why?
|
Female | 12 | 2021 | 397192 | 0.020 |
Why?
|
Adult | 7 | 2017 | 223646 | 0.020 |
Why?
|
Drug Resistance | 1 | 1996 | 1599 | 0.020 |
Why?
|
Mice | 4 | 2000 | 82029 | 0.020 |
Why?
|
Fees and Charges | 1 | 1991 | 189 | 0.020 |
Why?
|
Retrospective Studies | 6 | 2021 | 81762 | 0.020 |
Why?
|
Primary Myelofibrosis | 1 | 1991 | 209 | 0.020 |
Why?
|
Recurrence | 2 | 2000 | 8509 | 0.020 |
Why?
|
Mastocytosis | 1 | 1991 | 150 | 0.020 |
Why?
|
Diagnosis-Related Groups | 1 | 1991 | 445 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13421 | 0.020 |
Why?
|
Middle Aged | 9 | 2024 | 223492 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2000 | 1907 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 1998 | 7477 | 0.020 |
Why?
|
Terminal Care | 1 | 2000 | 1770 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15948 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2000 | 2333 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 1992 | 1525 | 0.020 |
Why?
|
Decision Making | 1 | 2000 | 3953 | 0.020 |
Why?
|
United States | 6 | 2008 | 73039 | 0.020 |
Why?
|
Gene Expression | 1 | 1998 | 7598 | 0.020 |
Why?
|
Genotype | 1 | 2000 | 13045 | 0.020 |
Why?
|
Marital Status | 1 | 2007 | 426 | 0.020 |
Why?
|
Health Maintenance Organizations | 1 | 2008 | 657 | 0.020 |
Why?
|
Animals | 4 | 2000 | 169246 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5367 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2000 | 4362 | 0.010 |
Why?
|
Health Resources | 1 | 1991 | 950 | 0.010 |
Why?
|
Risk Assessment | 2 | 2021 | 24315 | 0.010 |
Why?
|
Escherichia coli | 1 | 1996 | 4214 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1998 | 12800 | 0.010 |
Why?
|
Fee-for-Service Plans | 1 | 2008 | 713 | 0.010 |
Why?
|
Risk Factors | 1 | 2010 | 74944 | 0.010 |
Why?
|
Gastritis | 1 | 2004 | 199 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2000 | 11928 | 0.010 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2001 | 40 | 0.010 |
Why?
|
Phenotype | 1 | 2000 | 16726 | 0.010 |
Why?
|
Vincristine | 1 | 2004 | 1040 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2001 | 325 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2008 | 1156 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2008 | 1835 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2001 | 1057 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2008 | 3556 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2004 | 2227 | 0.010 |
Why?
|
Pregnancy | 1 | 2000 | 30256 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 2004 | 837 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2001 | 11095 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54926 | 0.010 |
Why?
|
Cause of Death | 1 | 2006 | 3721 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1245 | 0.010 |
Why?
|
Palliative Care | 1 | 1991 | 3643 | 0.010 |
Why?
|
Disease Progression | 2 | 2004 | 13671 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12077 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2008 | 7852 | 0.010 |
Why?
|
Mutation | 1 | 1998 | 30238 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10590 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12543 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6124 | 0.010 |
Why?
|
NF-kappa B | 1 | 2000 | 2493 | 0.010 |
Why?
|
Crohn Disease | 1 | 2004 | 2295 | 0.010 |
Why?
|
Registries | 1 | 2008 | 8375 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1992 | 11519 | 0.010 |
Why?
|
Heart Diseases | 1 | 2004 | 2819 | 0.010 |
Why?
|
Age Factors | 1 | 2008 | 18412 | 0.010 |
Why?
|
Data Collection | 1 | 2000 | 3327 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2000 | 2430 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2001 | 3474 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2000 | 4912 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 60066 | 0.000 |
Why?
|
Emotions | 1 | 2000 | 2767 | 0.000 |
Why?
|
Skin | 1 | 2001 | 4503 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2008 | 39348 | 0.000 |
Why?
|
Cohort Studies | 1 | 2006 | 41754 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2008 | 65371 | 0.000 |
Why?
|
Hospitalization | 1 | 2000 | 10840 | 0.000 |
Why?
|
Prognosis | 1 | 2000 | 30010 | 0.000 |
Why?
|
Quality of Life | 1 | 2000 | 13490 | 0.000 |
Why?
|
Signal Transduction | 1 | 2000 | 23645 | 0.000 |
Why?
|